Search Results

1 - 7 of 7 items :

  • "primary central nervous system lymphoma" x
Clear All

References 1. Haldorsen IS, Kråkenes J, Krossnes BK, Mella O, Espeland A. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol 2009; 30: 744-51. 2. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000; 92: 261-6. 3. Schlegel U, Schmidt-Wolf IG, Deckert M. Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 2000; 181: 1-12. 4. Olson

AIDS by using positron emission tomography. Ann Intern Med 1995; 123: 594-8. 4. Di Chiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 1987; 22: 360-71. 5. Kuwabara Y, Ichiya Y, Otsuka M, Miyake Y, Gunasekera R, Hasuo K, et al. High [18F]FDG uptake in primary cerebral lymphoma: a PET study. J Comput Assist Tomogr 1988; 12: 47-8. 6. Mohile NA, Deangelis LM, Abrey LE. The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro Oncol 2008

References 1. Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol. 2006; 24:1281-8. 2. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer. 1988; 62:2461-5. 3. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med. 1993; 119:1093-104. 4. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am. 1999; 28: 81-117. 5. Gavrilovic IT, Hormigo A, Yahalom J, DeAngelis LM, Abrey LE. Long-term follow-up of high

-1989. Cancer 1994; 74: 1383-97. 4. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993; 119: 1093-104. 5. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988; 68: 835-53. 6. Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Savkova RF, et al. Solid tumors in young children in Moscow Region of Russian Federation. Radiol Oncol 2008; 42: 39-44. 7. Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol 1999; 43: 199-201. 8. Bhagavathi S, Wilson JD. Primary central nervous system lymphoma

optimize brief cognitive batteries for brain tumor clinical trials. J Neurooncol 2010;96(2):271-6. 9. Weitzner MA, Meyers CA. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology, 1997; 6:169-77. 10. Correa DD, DeAngelis LM, Shi W, et al. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 2004;62:548-55. 11. Harder H, Holtel H, Bromberg JEC, et al. Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 2004;62:544-7. 12. Heimans JJ, Taphoorn

-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin. Am J Haematology 2004; 76: 236-9. 52. ASADA N., ODAWARA J., KIMURA S., AOKI T., YAMAKURA M., TAKEUKI M., SEKI R., TANAKAN A., MATSUE K. Use of random skin biopsy for the diagnosis of intravascular large B-cell lymphoma. Mayo Clin Proc 2007; 93: 1525-7. 53. OOMURA M., SAKAKIBARA N., SUZUKI S., WAKITA A., MORI Y., KAMIMOTO K. Intravascular lymphomatosis mimicking primary central nervous system lymphoma: A case report and literature review. Case Reports in Neurology 2014; 6: 101-8. 54

patients with systemic lymphoma as well as of patients with primary central nervous system lymphoma 15 , the standardised uptake for cerebral lesions is much higher than in toxoplasma lesions 8 . Cerebral toxoplasmosis in HIV-negative patients has been most commonly described in patients after BMT due to underlying lymphoma or leukemia. There are only rare reports of toxoplasmosis in patients with hematologic malignancies, independent of BMT. 16 , 17 Despite clinical advancements and good safety profiles, chemotherapeutics, especially T and B cell depleting regimens